Tau aggregation in the hippocampal formation: an ageing or a pathological process?

Area of Science:

• Neuroscience
• Neuropathology
• Gerontology

Background:

• Tauopathy, a dysfunction of tau proteins, is linked to dementing disorders and neurodegeneration in aging and Alzheimer's disease (AD).
• The relationship between tauopathy in the hippocampal formation, aging, AD, and cognitive decline remains incompletely understood.
• Alzheimer's disease involves APP dysfunction and tauopathy in neocortical areas, correlating with cognitive impairment.

Purpose of the Study:

• To investigate the relationship between tauopathy in the hippocampal formation, aging, Alzheimer's disease, and cognitive impairment.
• To clarify whether hippocampal tauopathy is age-dependent or age-related and its independence from AD.
• To explore tauopathy as a potential therapeutic target for delaying AD progression.

Main Methods:

• Multidisciplinary analysis of human brain samples from non-demented and demented individuals.
• Comparative study of tauopathy patterns in the hippocampal formation across different age groups and disease states.
• Correlation analysis between tauopathy, aging, APP dysfunction, and cognitive status.

Main Results:

• Hippocampal tauopathy is age-related but not strictly age-dependent in humans.
• This form of tauopathy is independent of Alzheimer's disease but can be amplified by APP dysfunction.
• Tauopathy in the entorhinal and hippocampal formation represents a distinct pathological tau dysfunction.

Conclusions:

• Hippocampal tauopathy is an age-related process, distinct from but influenced by Alzheimer's disease pathology.
• Targeting tauopathy in the entorhinal and hippocampal formation may offer a strategy to delay AD.
• Development of relevant animal models is crucial for further research into hippocampal tauopathy and its therapeutic potential.